The Global Dysmenorrhea Treatment Industry, a crucial player in women’s health, has demonstrated robust growth, reaching a valuation of US$ 5,937.8 million by the end of 2022. As we usher in 2023, the market is poised to experience even greater demand, with an estimated value of US$ 6,324.5 million, reflecting an impressive year-on-year growth rate …
Category Archives: Healthcare Trends
Global Embryo Incubator Industry Set to Soar to US$ 137.7 Million by 2033, Fueled by a 5.4% CAGR | Insights by FMI
The Global Embryo Incubator Industry has achieved remarkable growth, reaching a valuation of US$ 77.8 million in 2022. This milestone showcases the industry’s unwavering commitment to advancing reproductive health technologies, catering to the evolving needs of healthcare professionals, and ensuring improved outcomes for patients worldwide. As we step into 2023, the trajectory of the Global …
Global Drug Delivery Technology Industry Set for Striking 12.6% CAGR, Eyes Surpassing US$ 143.5 Billion by 2033 | According to FMI
The Global Drug Delivery Technology Market is estimated to secure a valuation of US$ 4.3 billion in 2023 and reach US$ 143.5 billion by 2033. The global market is anticipated to register a CAGR of 12.6% during the forecast period. Request a Sample of this Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-1166 How are Manufacturers Bringing New Opportunities in …
Global Cloud Based Drug Discovery Platform Industry Surges with a Projected 12.6% CAGR, Valued at US$ 7,529.59 Million by 2032 | FMI
The Global Cloud-Based Drug Discovery Platform Industry is set to embark on an unprecedented growth trajectory, with a robust Compound Annual Growth Rate (CAGR) of 12.6% anticipated throughout the forecast period. In 2022, the market is already making waves, reaching an estimated worth of US$ 2,424.33 Million. By the year 2032, industry experts predict a …
Chemotherapy-Induced Treatment Market Envisions a Steady 3.2% CAGR Journey Through 2028-FMI Study
The chemotherapy-induced myelosuppression treatments market is expected to increase from its present size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028, with a cumulative annual growth rate (CAGR) of 3.3%. A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y …
Antibiotic Susceptibility Testing Market Sets Sights on US$ 4.05 Billion Revenue by 2028-FMI Study
In 2021, the antibiotic susceptibility testing market generated US$ 2.82 billion in revenue. By 2028, the global market is projected to have grown at a compound annual growth rate of 5.2% and be valued US$ 4.05 billion. •Infectious diseases, prevailing at a high pace •Increasing rate and tenure of hospitalization •Growing significance of early diagnostics …
Laboratory Balances and Scales Market Surges Beyond US$ 2.0 Billion by 2033-FMI Study
The laboratory balances and scales market is anticipated to expand at a 4.3% average CAGR between 2023 and 2033. By 2033, the market is expected to have a market share of US$ 2.0 billion, up from the projected value of US$ 1.31 billion in 2023. •The market expansion is fueled by the increased use of precise and …
Prothrombin Complex Concentrates Market Sets Sail on a US$ 1.2 Billion Odyssey by 2033-FMI Study
The prothrombin complex concentrates market is anticipated to reach a valuation of US$ 1.2 billion by 2033, from a projected US$ 772.0 million in 2023. Prothrombin complex concentrate demand is predicted to grow at a consistent 4.1% CAGR, with China, India, the United States, and the United Kingdom emerging as major manufacturers.. The global Prothrombin …
Frontotemporal Disorders Treatment Market Charts Course for a Remarkable US$ 451.4 Million by 2028-FMI Study
According to the company’s latest research, the frontotemporal disorders treatment market is expected to reach a valuation of US$ 451.4 million by the end of 2028. According to the frontotemporal disorders therapy market research, there is tremendous development potential through 2028, with an average annual growth rate of 4.7%. The increasing funding by the governments …
Airway Management Devices Market Set to Surge, Anticipating a US$ 2.2 Billion Milestone by 2033-FMI Study
The airway management devices market is anticipated to be valued US$ 1.6 billion in 2023 and grow at a 3.6% CAGR to reach US$ 2.2 billion by 2033. The rising frequency of respiratory disorders is expected to be one of the market’s key driving forces. The WHO estimates that 65 million people have moderate-to-severe COPD. …